Jinling Pharmaceutical Co Ltd Class A 000919
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- —–—
- 52-Week Range
- —–—
- Bid/Ask
- — / —
- Market Cap
- —
- Volume/Avg
- — / —
Key Statistics
- Price/Earnings (Normalized)
- 56.62
- Price/Sales
- 1.16
- Dividend Yield (Trailing)
- 1.61%
- Dividend Yield (Forward)
- 1.61%
- Total Yield
- 1.61%
Company Profile
Jinling Pharmaceutical Co Ltd is a China-based pharmaceutical company.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 4,871
- Website
- http://www.jlyy000919.com
Comparables
Valuation
|
Metric
|
000919
|
600211
|
301075
|
|---|---|---|---|
Price/Earnings (Normalized) | 56.62 | 11.86 | — |
Price/Book Value | 1.03 | 2.99 | 1.90 |
Price/Sales | 1.16 | 3.87 | 4.44 |
Price/Cash Flow | 15.12 | 8.99 | 125.32 |
Price/Earnings
000919
600211
301075
Financial Strength
|
Metric
|
000919
|
600211
|
301075
|
|---|---|---|---|
Quick Ratio | 3.28 | 2.65 | 7.18 |
Current Ratio | 3.61 | 2.80 | 8.32 |
Interest Coverage | 388.44 | 72.67 | −0.50 |
Quick Ratio
000919
600211
301075
Profitability
|
Metric
|
000919
|
600211
|
301075
|
|---|---|---|---|
Return on Assets (Normalized) | 1.25% | 14.77% | −0.52% |
Return on Equity (Normalized) | 1.83% | 20.58% | −0.71% |
Return on Invested Capital (Normalized) | 1.04% | 16.12% | −0.76% |
Return on Assets
000919
600211
301075
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Hswcqljmj | Ytcy | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Ngjsfkqkz | Mcysxn | $77.4 Bil | |||
| Haleon PLC ADR
HLN
| Lgztmfmvc | Vwj | $47.3 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Hrzkxhf | Zts | $19.0 Bil | |||
| Viatris Inc
VTRS
| Fksmwnyv | Zksn | $13.9 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Pxpbtblw | Njzw | $13.4 Bil | |||
| Catalent Inc
CTLT
| Wcrjghmp | Dtbtvf | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Mzlflcmw | Rbmlxkg | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Vthjhnjs | Lyqtr | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Cqmtvvjc | Gwl | $2.5 Bil |
United States